Based on the New Medical Technologies CenterNew Medical Technologies Company was created to develop and implement innovative technologies in the field of medicine. The company's specialists conduct scientific and practical developments on the basis of the reference laboratory of the Institute of Virology of the Ministry of Health of the Republic of Uzbekistan, as well as the scientific and practical laboratory of Uzbek Scientific Research Institute of Epidemiology, Microbiology and Infectious Diseases (USRIEMID), the purpose of which is to prevent infection of patients of medical institutions of various profiles with viruses, an effective cure for which has not yet been created. New methods of sterilization and storage of sterile instruments for medical, hairdressing and household purposes are being developed. Studies are being conducted to identify the mechanisms of virus transmission. Since the establishment of the company (2008), more than 120 successful studies have been conducted on the basis of various research institutes to test the effectiveness of the installation developed by the company and the method for assessing the viability of viruses with lymphotropism on various strains of viruses, bacteria, spores and fungi. The effectiveness of the installation and the developed methods has been proven by the results of research and recognized by leading specialists and experts of the Ministry of Health of the Republic of Uzbekistan.
Method for detecting and evaluating the viability of lymphotropic viruses.The present method of detecting lymphotropic viruses is intended for:
Virus inactivation installationIt is intended for inactivation of viruses on medical instruments (surgical, dental, gynecological, otolaryngological, ophthalmological and others) in medical institutions of various profiles. The effectiveness of the installation has been proven experimentally on viruses of the vaccine strain of polio, Crimean-congohemorrhagic fever virus, influenza, hepatitis B and C, as well as HIV infection. The installation is registered with the Committee on New Medical Devices and Medicines (General Directorate for Quality Control of Medicines and Medical Equipment) and the Uzbek Agency for Standardization, Metrology and Certification (Uzstandart Agency).
The range of applications of the method for detecting and evaluating the viability of lymphotropic HBV, HCV and HIV viruses.
Blood transfusion stations:to increase the reliability of detection of lymphotropic hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) in biological media (donor blood, plasma and other components) containing viruses in concentrations below the threshold of sensitivity of ELISA or PCR methods.
Diagnostic laboratories:to increase the reliability and exclude false negative results when testing for HBV, HCV or HIV infection in the blood of donors or patients with virus content in concentrations below the sensitivity threshold of ELISA or PCR methods.
Pharmaceutical companies:to assess the viability of HBV, HCV or HIV viruses after exposure to chemical and physical antiviral factors developed and offered by manufacturers in order to inactivate viruses at various facilities.
The method creates the opportunity:objectively evaluate the effect of chemical or physical factors on the viability (pathogenicity) of lymphotropic viruses.
Allows to eliminate errorsin the diagnosis of patients, when testing donated blood and its components for infection with lymphotropic viruses HBV, HCV or HIV.
Detectionand evaluation of the viability of lymphotropic viruses has no analogues.
According to this method of detecting and assessing the viability of viruses with lymphotropism, the State Patent Office of the Republic of Uzbekistan has issued a patent registered in the State Register of utility models of the Republic of Uzbekistan in Tashkent for No. IAP 04903 dated 06/18/2012.
Patents have been obtained for the invention (according to the method of assessing the viability of lymphotropic viruses) in the European, Eurasian Patent Offices, as well as patent offices of the following countries - Africa, USA, Israel, UAE, India.Patents and certificates Documents